Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-27 Sale | 2024-09-27 7:32 pm | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 50,000 | $45.96 | $2,297,755 | 168,259 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-19 Exercise | 2024-12-20 6:25 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 9,880 | $20.24 | 264,342 (Direct) | View |
| 2024-12-19 Exercise | 2024-12-20 6:25 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 1 | $14.02 | 264,342 (Direct) | View |
| 2024-12-19 Exercise | 2024-12-20 6:25 pm | N/A 2032-01-02 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 9,881 | $0 | 264,342 (Direct) | View |
| 2024-09-27 Exercise | 2024-09-27 7:32 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 50,000 | $4.21 | 168,259 (Direct) | View |
| 2024-09-27 Exercise | 2024-09-27 7:32 pm | N/A 2031-03-09 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 50,000 | $0 | 168,259 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 4:50 pm | N/A 2034-01-01 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:33 pm | N/A 2033-01-02 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 5:26 pm | N/A 2032-01-02 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 106,750 | $0 | 106,750 (Direct) | View |
Ownership | 2021-06-10 7:15 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 0 | $0 | 338,183 (Direct) | View |